Lupartumab

Modify Date: 2024-01-22 08:57:04

Lupartumab Structure
Lupartumab structure
Common Name Lupartumab
CAS Number 1640971-88-5 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Lupartumab


Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980[1].

 Names

Name Lupartumab

 Lupartumab Biological Activity

Description Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980[1].
Related Catalog
Target

LYPD3 (C4.4A)[1]

References

[1]. Willuda J, et al. Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer. Mol Cancer Ther. 2017 May;16(5):893-904.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties
Top Suppliers:I want be here

No recommended suppliers.


Get all suppliers and price by the below link:

Lupartumab suppliers

Lupartumab price